PTGX PROTAGONIST THERAPEUTICS

Health Care · Russell 2000

Next earnings: not announced yet

What 19 analyst firms say about PROTAGONIST THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

132.04 USD−3.22 (−2.38%) today

Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+29.1%to the avg target 170.44 USD+38.40 USD

Buy 17 · Hold 0 · Sell 0

17 rated views · 19 analyst/firm records · 19 firms

Latest report21 Oct 2026avg report date 10 Aug

Target rangeLowest to highest analyst target, not a forecast

now 132.04

Radar score

Russell 2000 · Top Picks · 6MGood · #29 in the index89
Russell 2000 · Safest consensus · 6MGood · #15 in the index87

Recent analyst activity · last 90 days

Our tracked history has 15 reports on PTGX from 13 analyst firms in the last 90 days (19 firms in the past year).

Comparing each firm's latest target with its previous one: 8 raised their price target, 2 left it unchanged and 2 have their first observed target in the past year.

Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.

Latest observed target change: TD Cowen raised its target from $100.00 (set 26 Feb 2026) to $160.00 on 21 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

Firm	Analyst	Latest rating	Report date	Latest target (USD)
Barclays	Etzer Darout	Buy	13 Oct 2026	180.00 USD
BMO Capital Markets	Evan Seigerman	Buy	26 Jun 2026	190.00 USD
Citigroup	Geoff Meacham	Buy	31 Aug 2026	182.00 USD
Citizens JMP	Jonathan Wolleben	Buy	17 Jul 2026	170.00 USD
Clear Street	Unnamed analyst	Buy	7 Apr 2026	116.00 USD
Clear Street LLC	Kaveri Pohlman	Buy	6 Aug 2026	173.00 USD
Goldman Sachs	Richard Law	Buy	10 Aug 2026	186.00 USD
H.C. Wainwright	Douglas Tsao	Buy	31 Aug 2026	170.00 USD
Jefferies	Roger Song	Buy	22 Jul 2026	171.00 USD
Johnson Rice	Unnamed analyst	—	17 Jul 2026	165.00 USD
JPMorgan	Brian Cheng	Buy	19 Mar 2026	106.00 USD
Leerink Partners	Will Soghikian	Buy	12 Oct 2026	190.00 USD
TD Cowen	Tara Bancroft	Buy	21 Oct 2026	160.00 USD
Truist	Srikripa Devarakonda	Buy	10 Aug 2026	170.00 USD
UBS	Alice Nettleton	Buy	12 Oct 2026	184.00 USD
Wedbush	Yun Zhong	Buy	10 Aug 2026	173.00 USD
Weiss Ratings	Unnamed analyst	—	23 Oct 2026	—
Wolfe Research	Alexandria Hammond	Buy	31 Aug 2026	225.00 USD
Data feed RESEARCH	Research Team	Buy	14 Oct 2026	157.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 08:15 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.